Oncogenic alternative splicing switches: role in cancer progression and prospects for therapy

Area of Science:

• Molecular Biology
• Cancer Research
• Genetics

Background:

• Alternative splicing is a key post-transcriptional regulatory mechanism.
• Dysregulation of alternative splicing contributes to cancer development, progression, and therapeutic resistance.
• Many cancer-associated genes are regulated by alternative splicing, impacting oncogene and tumor suppressor production.

Purpose of the Study:

• To investigate the role of alternative splicing in cancer.
• To understand the molecular basis of cancer-associated alternative splicing isoforms.
• To identify novel tumorigenesis-specific pathways and therapeutic targets.

Main Methods:

• Analysis of alternative splicing regulators and their activities.
• Identification and characterization of alternatively spliced variants in cancer.
• Investigation of the contribution of alternative splicing to cancer hallmarks.

Main Results:

• Alterations in alternative splicing regulators lead to aberrant splicing variants.
• These variants play a significant role in tumor establishment, progression, and resistance to therapy.
• Alternative splicing is implicated in the production of key oncogenes and tumor suppressors.

Conclusions:

• Understanding cancer-associated alternative splicing provides insights into malignant transformation.
• Targeting alternative splicing mechanisms offers potential for novel anti-cancer strategies.
• This research highlights opportunities to improve the efficacy of cancer treatments.